15:55 Apr 29

Alkem Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5030.80
+5.00 (+0.10%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alkem Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5030.80
+5.00 (+0.10%)
15:55 Apr 29
Quality
image/svg+xml

84/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

48/100
Technically Neutral

Strength

6

Weakness

2

Opportunity

1

Threats

0

17.41 %

ROE %

11.52 %

ROA %

180.08

EPS

896.23

BVPS

14.17 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
8865.01 10634.19 11599.26 12667.58 12756.59
Operating Expenses +
6922.62 8581.27 9989.81 10422.09 10233.75
Raw Material
3832.3 4715.77 4444.47 4923.46 4976.86
Increase Decrease in Cost
-333.84 -535.48 462.37 14.12 -384.48
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1621.03 1962.71 2131.35 2201.01 2343.4
Miscellaneous Expenses
4678.65 5417.69 5726.72 6541.24 3297.97
Operating Profit
1942.39 2052.92 1609.45 2245.49 2522.84
Other Income
233.21 162.65 216.08 310.84 435.95
Depreciation
274.58 303.96 310.42 299.3 328.1
Interest
58.92 52.37 107.36 112.41 120.14
Profit before tax and exceptio..
1842.1 1859.24 1407.75 2144.62 2510.55
Exceptional Items
0 -14.96 -102.98 -121.49 -12.52
PBT
1842.1 1844.28 1304.77 2023.13 2523.07
Provision for Taxation
224.33 163.96 297.96 211.67 300.56
Net Profit
1617.77 1680.32 1006.81 1811.46 2197.47
NET Profit after MI
1585.02 1645.62 984.17 1795.77 2153.18
EPS
132.57 137.63 82.31 150.19 180.09
Operating Profit Margin (%)
21.91 19.3 13.88 17.73 19.78
Net Profit Margin (%)
17.88 15.47 8.48 14.18 16.88

ShareHolding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 55.10 55.70 55.70 56.40 56.70
FII 9.40 10.10 9.00 8.70 9.10
MF 15.00 14.00 14.90 14.70 11.90
Public 16.00 16.20 16.10 16.40 18.50
Others 0.10 0.00 0.00 0.00 0.10
Others 4.40 4.00 4.30 3.80 3.70
Shareholder Shares Holding %

Download Our App On: